Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)

Farhad Salehzadeh,1 Yusef Mohammadikebar,2 Afsaneh Enteshary,2 Omid Ghanbarpour,1 Mehrdad Mirzarahimi11Department of Pediatric, Bouali Children’s Hospital, Ardabil University of Medical Sciences (ARUMS), Ardabil, Iran; 2Department of Internal Medicine, Emam Khomeini Hospital, Ardabil Unive...

Full description

Bibliographic Details
Main Authors: Salehzadeh F, Mohammadikebar Y, Enteshary A, Ghanbarpour O, Mirzarahimi M
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Biologics: Targets & Therapy
Subjects:
Pyoderma Gangrenousm
Infliximab
Childhood
Online Access:https://www.dovepress.com/infliximab-in-treatment-of-idiopathic-refractory-childhood-pyoderma-ga-peer-reviewed-article-BTT

Internet

https://www.dovepress.com/infliximab-in-treatment-of-idiopathic-refractory-childhood-pyoderma-ga-peer-reviewed-article-BTT

Similar Items